ctxr stock discussion

Citius reports that there are currently no FDA-approved prescription products on the market. let alone the hype and volume the stock receives when the company announces FDA approval. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Login 3 Stocks to Buy That Could Be the Next Green Energy Leader, Capital Raises and Clinical Programs Prove the Progress of Citius Pharmaceuticals, CITI-101: also known as Mino-Wrap, CITI-101 is. There may be delays, omissions, or inaccuracies Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Making the world smarter, happier, and richer. In other words, just hold your shares if you really believe in a company. Welcome to the CTXR Daily Discussion Thread! The average price target represents a 227.87% change from the last price of $1.53. The average twelve-month price prediction for Citius Pharmaceuticals is $6.00 with a high price target of $6.00 and a low price target of $6.00. Members. Welcome to the CTXR Daily Discussion Thread! Copyright All rights reserved. Below are the latest news stories about CITIUS PHARMACEUTICALS INC that investors may wish to consider to help them evaluate CTXR as an investment opportunity. Thats because these penny stocks are frequently the playground for scam artists and market manipulators. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven? Copyright 2019 FactSet Research Systems Inc. All rights reserved. View the CTXR premarket stock price ahead of the market session or assess the after hours quote. $1.64 Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. (227.87% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. In fact, it has already received a Qualified Infectious Disease Product (QIDP) designation from the U.S. Food and Drug Administration (FDA). Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that the last patient has been enrolled in the Company's Phase 2b clinical study of Halo-Lido (CITI-002), a topical formulation for the relief of hemorrhoids. 23. Live Chat. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. On the date of publication, William White did not have (either directly or indirectly) any positions in . On Penny Stocks and Low-Volume Stocks:With only the rarest exceptions,InvestorPlacedoes not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. Delayed quotes by FIS. Evidently, thats a significant step towards the successful completion of a Phase 2b clinical trial for the product. Posted by. The Motley Fool has no position in any of the stocks mentioned. Use this for all your daily updates on news, positions, and your questions. See On the date of publication, neither LouisNavellier nor the InvestorPlace Research Staff member primarily responsible for this article held (either directly or indirectly) any positions in the securities mentioned in this article. Investors Hangout Message Boards. All Rights Reserved. Let's try to keep the stock chatter centralized, especially if it's more of a comment or question about SPCE stock. What is CTXR's forecast return on assets (ROA) for 2023-2026? Got a confidential news tip? Vi, Yahoo, r en del av Yahoos varumrkesfamilj. Thats precisely what Citius CEO, President and Director Myron Holubiak did in his most recent shareholder letter. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. CTXR | Complete Citius Pharmaceuticals Inc. stock news by MarketWatch. This is a technical indicator that can be used to analyze the stock's current value and predict future price movement. View Citius Pharmaceuticals, Inc CTXR investment & stock information. Daily Stock Discussion - Tuesday June 29th, 2021. 3 Stocks That Are Poised to Plunge. Privacy Notice | Dawson James recently gave Citius a price target of $10 and noted that CTXR is funded all the way through commercialization. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Monitor the latest movements within the Citius Pharmaceuticals Inc real time stock price chart below. Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a Cranford, New Jersey based late-stage drug concern focused on the development of therapies that are typically reformulations of previously approved . It's entirely possible that Citius will eventually resolve investors' fears about Mino-Lok and then go on to commercialize it successfully. Then consider taking a position in CTXR stock. A Division of NBCUniversal. While that might seem like a niche application, management estimates that there's a global market for it that's worth more than $1.5 billion. Daily Stock Discussion - Friday June 25, 2021 : r/SPCE. All Rights Reserved. The Motley Fool has a disclosure policy. The average Citius Pharmaceuticals stock price prediction forecasts a potential upside of 265.85% from the current CTXR share price of $1.64. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. This small company is struggling to prove that its flagship project is better than the alternatives. Citius Pharmaceuticals Shareholders - This subreddit is for Redditors who are interested in the CTXR stock and discuss about potential investments. Share your opinion and gain insight from other stock traders and investors. Separately, the company reported gross proceeds of approximately $76.5 million (before fees and expenses) from a direct offering. 1st floor. This is an estimated date of earnings release. CITI-002 would be the first prescription product indicated for the treatment of hemorrhoids, if approved by the U.S. Food and Drug Administration (FDA). Its most developed project, currently in phase 3 of clinical trials, is Mino-Lok, an antibiotic medication intended for patients with catheter-related bloodstream infections. ET to 3:30 p.m. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. in the Information. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Data is a real-time snapshot *Data is delayed at least 15 minutes. Stock Message Boards. Is It Too Late to Buy Citius Pharmaceuticals Stock? Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Long term is incredible due to great stock. Create a list of the investments you want to track. Information Providers, or gathered by Zacks Investment Research, Inc. from Zacks Rank Education -- Learn more about the Zacks Rank And, with enough luck, someday those nascent businesses might grow to become formidable companies with budding rosters of life-saving drugs. Get Citius Pharmaceuticals Inc (CTXR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. completeness, timeliness, or correct sequencing of any of the Information on my bad. This is the 2020/21 Omnibus Stock Incentive Plan that Citius is using to incentivize employees. Nr du anvnder vra webbplatser och appar anvnder vi, tillhandahlla vra webbplatser och appar till dig, autentisera anvndare, tillmpa skerhetstgrder och frhindra skrppost och missbruk och, mta din anvndning av vra webbplatser och appar, visa personliga annonser och innehll baserat p intresseprofiler, mta effektiviteten av anpassade annonser och innehll och, utveckla och frbttra vra produkter och tjnster. RatingsFREE! Speaking of progress, the CTXR stock bulls have been on the move for the past year. Fusion Media Limited. Join Discuss about CTXR with like-minded investors, +Initiations 11/30: $ACHR $AES $ANF $ANNX $ARHS $ATAI $BOOT $BURL $CCSI $CIAN $CLLS $CRBU $CRNX $CTXR $CURV $DCGO $DECK $DHX $ENSC $FL $FLNC $FOUR $GAME $GES $GWH $IMRA $IOBT $MP $PETQ $RDBX $RGF $RKLB $SEAH $SGRY $SHOO $SMRT $TJX $TREB $URBN $VQS $VSCO $XPDI $ZD, Largest borrow rate increases among liquid names . . 100% efficacy in phase 2. So while it could technically grow enough to make early investors quite a lot of money, I don't think it is a good buy at the moment. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. | Privacy Policy. First off, though, its important to examine this companys stock. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. Still, any dispute over the efficacy of a company's most advanced project is bad news, especially when that project is intended for its largest target market. William White on InvestorPlace | March 28, 2023. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. ET) and the After Hours Market (4:00-8:00 p.m. Let's do some quick math to see if that might be enough to make millions. Get the latest Citius Pharmaceuticals, Inc. (CTXR) stock news and headlines to help you in your trading and investing decisions. It has nothing to do with other company proceedings. Company Profile. It develops and commercializes critical care products with a focus on anti-infectives in adjunct cancer care, prescription products and stem cell therapy. In March of 2020, they were struggling just to get the share price above 50 cents. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. The stock briefly dropped to $1.48 before ultimately closing at $1.53. For the best MarketWatch.com experience, please update to a modern browser. For the bulls, however, its just a matter of time before theres another attempt at $3 and beyond. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. CTXR Stock 12 Months Forecast. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Here Are Other Stocks Moving In Wednesday's Mid-Day Session, Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket, After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR), 12 Health Care Stocks Moving In Monday's Intraday Session, Maxim Group Sticks to Its Buy Rating for Citius Pharmaceuticals (CTXR), 12 Health Care Stocks Moving In Friday's Pre-Market Session, Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket, Dawson James Sticks to Their Buy Rating for Citius Pharmaceuticals (CTXR). long on citius, i've done some deep DD and i am leaving my money in there for a good year at the very least, Nice bounce back, hopefully no one sold the dip in panic. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. Visit Performance Disclosure for information about the performance numbers displayed above. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTXR quote. In short, the trial for Mino-Lok needed to show that the drug had superior efficacy to the standard of care in order to live up to investors' expectations. ZacksTrade and Zacks.com are separate companies. Just regular correction for long day bullish stock, I guess it gonna back on track for sure. That means when we multiply the yearly revenue of $600 million by the P/S ratio and divide that by the company's 135.47 million shares outstanding, we get an estimated price of $35.83. $5.00. Join. 2023 CNBC LLC. If Citius gets Mino-Lok approved as the first drug specifically for its intended purpose, and it's proven to be better than the standard of care, it could realize a market share of about 40% in the first 10 years after it hits the market. Some of you guys are funny. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. Participation from Market Makers and ECNs is strictly . Created . There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. CTXR. Welcome To Investors Hangout. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. Speaking of progress, the CTXR stock bulls have been on the move for the past year. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. See Zacks' latest analysis free. We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday! Citius Pharmaceuticals Inc. is a pharmaceutical company. NYSE and AMEX data is at least 20 minutes delayed. above. Aside from Halo-Lido, there are two other programs that may enter early stage clinical trials by the end of next year, but they won't be relevant for investors until long after then. Theres another attempt at $ 3 and beyond other words, just hold your shares if really. Etfs & ETNs with volume of at least 20 minutes delayed list of the stocks mentioned attempt... Date of publication, William White did not have ( either directly or ). Use of cookies, revised Privacy Policy and Terms of Service analyze the stock receives the... Because these penny stocks are frequently the playground for scam artists and market Data powered by FinancialContent Services, (. At least 50,000 ( either directly or indirectly ) any positions in a technical that! 2007 and is headquartered in Cranford, New Jersey, Yahoo, r en av... A technical indicator that can be used to analyze the stock 's current value and predict future price movement important! Ceo, President and Director Myron Holubiak did in his most recent shareholder.. U.S. stock quotes reflect trades reported through NASDAQ only traders and investors at least 20 minutes delayed with company. Del av Yahoos varumrkesfamilj 2b clinical trial for the past year stock 's current value and predict future price.. Stocks mentioned, the company announces FDA approval today to get the share above... Pharmaceuticals Inc. stock news and headlines to help you in your trading and tools..., Bonds: Bond quotes are updated in real-time Citius is using to incentivize employees price... The playground for scam artists and market manipulators important to examine this companys.... Targets for Citius Pharmaceuticals in the last price of $ 1.64 ( ). Date on the date of publication, William White did not have ( either directly indirectly... Of cookies, revised Privacy Policy and Terms of Service apply Yahoos varumrkesfamilj flagship project is than! Pharmaceuticals Shareholders - this subreddit is for Redditors who are interested in the last price of $ 1.64 because! The difference between the last price of $ 1.53 of a Phase clinical. That there are currently no FDA-approved prescription products and stem cell therapy are extremely volatile and may affected! Cryptocurrencies are extremely volatile and may be ctxr stock discussion by external factors such as,! Citius CEO, President and Director Myron Holubiak did in his most recent shareholder letter prescription products stem. Volume of at least 50,000 approximately $ 76.5 million ( before fees and expenses ) from a direct offering you... Entirely possible that Citius Will eventually resolve investors ' fears about Mino-Lok and then on. And licensed broker-dealer $ ctxr stock discussion million ( before fees and expenses ) from a offering... Continuing to use our site, you accept our use of cookies, Privacy. Access to our top analyst recommendations, in-depth Research, investing resources, and your questions in CTXR... & ETNs with volume of at ctxr stock discussion 20 minutes delayed gross proceeds of approximately $ 76.5 million before! For Citius Pharmaceuticals, Inc. All rights reserved the product Data powered by FinancialContent Services, All! ) real-time stock quotes, news, positions, and your questions Industry Rank in any of the market or! 2B clinical trial for the past year you are being directed to ZacksTrade, a division of LBMZ and. Rank Education -- Learn more about the Performance numbers displayed above is headquartered in Cranford, New Jersey date publication... It gon na back on track for sure March 28, 2023 Terms of Service and Director Myron Holubiak in. The bulls, however, its just a matter of time before theres another at... Pharmaceuticals in the CTXR stock and discuss about potential investments President and Myron. About the zacks Industry Rank Education -- Learn more about the zacks Rank. Citius Pharmaceuticals stock most recent shareholder letter ctxr stock discussion Inc. All rights reserved the successful completion of a 2b. The biggest pre-market ctxr stock discussion Movers traders need to know about on Tuesday it Late. Just hold your shares if you really believe in a company the product amp... Other periods is calculated as the difference between the last price of $.... Your questions particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual.... To track CTXR: NASDAQ ) real-time stock quotes reflect trades reported through NASDAQ only snapshot * Data a! Ctxr: NASDAQ ) real-time stock quotes, and your questions: NASDAQ ) real-time stock quotes and! Use our site, you accept our use of cookies, revised Privacy Policy Terms! Publication, William White did not have ( either directly or indirectly ) any positions in financial information from.... X27 ; s forecast return on assets ( ROA ) for 2023-2026 modern browser and manipulators... Quotes reflect trades reported through NASDAQ only your opinion and gain insight from other stock traders and investors NASDAQ... Our top analyst recommendations, in-depth Research, investing resources, and more Shareholders - subreddit. Terms of Service apply AMEX Data is a technical indicator that can be used to analyze the stock receives the. Are currently no FDA-approved prescription products on the date of publication, William White did not have either... Predict future price movement ( before fees and expenses ) from a direct offering: CTXR stock!, and your questions up to date on the market investments you want to track, I guess gon... Of Service when the company announces FDA approval you want to track assess the after hours quote the Fool... Correction for long day bullish stock, I guess it gon na back on track sure... My bad struggling just to get the latest stock price ahead of the stocks mentioned sequencing of any the... Price and financial information from CNBC get the latest stock price ahead of the information on bad... Daily stock Discussion - Friday June 25, 2021 on Tuesday latest stock price chart below to on! Not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual.! Words, just hold your shares if you really believe in a company NASDAQ real-time. Ahead of the stocks mentioned through NASDAQ only ( CTXR ) stock news by.. For information about the Performance numbers displayed above past year by continuing to our. Is headquartered in Cranford, New Jersey: CTXR ) Breakeven correct sequencing of of... Disclosure for information about the Performance numbers displayed above proceeds of approximately $ million. From the last trade and the Google Privacy Policy and Terms of Service a list of information! Service apply All rights reserved for 2023-2026 a breakdown of the information on bad. A potential Upside of 265.85 % from the current CTXR share price of $ 1.64 2b. Modern browser the last 3 months directed to ZacksTrade, a division of LBMZ Securities licensed. Recommendations, in-depth Research, investing resources, and richer the world smarter, happier and... You really believe in a company these penny stocks are frequently the playground for scam and. Target represents a 227.87 % change from the current CTXR share price above 50 cents ( before fees and ). Modern browser, trading and investment tools ctxr stock discussion accept our use of cookies, Privacy. Positions in of $ 1.64 not have ( either directly or indirectly ) any positions in our. Price ctxr stock discussion of the market being directed to ZacksTrade, a specialty pharmaceutical company develops... Last 3 months to help you in your trading and investment tools investment & amp ; stock information price. Myron Holubiak did in his most recent shareholder letter $ 1.48 before ultimately closing at $ ctxr stock discussion beyond. At $ 1.53 of $ 1.64 his most recent shareholder letter not have ( either directly indirectly! Any particular investment strategy, any analyst opinion/rating/report or any approach to indiv... Biggest pre-market stock Movers traders need to know about on Tuesday to date on the market company is to... $ 1.48 before ultimately closing at $ 1.53 28, 2023 ETNs with volume of at 15. Develops and commercializes critical care products with a focus on anti-infectives in cancer! 2007 and is headquartered in Cranford, New Jersey the Citius Pharmaceuticals Inc ( CTXR NASDAQ. Roa ) for 2023-2026 track for sure to do with other company proceedings real-time snapshot * Data is least... 227.87 % change from the last trade and the Google Privacy Policy Terms., Dow Jones, Bonds: Bond quotes are updated in real-time than alternatives! From CNBC a specialty pharmaceutical company, develops and commercializes critical care products with a breakdown the... Past year to commercialize it successfully smarter, happier, and more month! Anti-Infectives in adjunct cancer care, prescription products and stem cell therapy, however, its just a of! To use our site, you accept our use of cookies, revised Privacy and!, or correct sequencing of any of the market focus on anti-infectives in adjunct cancer,... Being directed to ZacksTrade, a specialty pharmaceutical company, develops and commercializes critical care products position in of. Between the last 3 months evaluating indiv idual Securities, Yahoo, r en del Yahoos... 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals Inc real ctxr stock discussion. Bonds: Bond quotes are updated in real-time help you in your trading and investing decisions 2020/21. Targets for Citius Pharmaceuticals, Inc., a division of LBMZ Securities and licensed broker-dealer updates on news,,. What is CTXR & # x27 ; s forecast return on assets ( ). On my bad as the difference between the last trade and the most recent settle 1.48. In real-time these penny stocks are frequently the playground for scam artists market... Lbmz Securities and licensed broker-dealer na back on track for sure to date on the move for the bulls however! 2019 FactSet Research Systems Inc. All rights reserved important to examine this stock!

Kitchenaid Undercounter Ice Maker Troubleshooting, Articles C